 |
 |

Episodic Hyperammonemia in Adult Siblings With Hyperornithinemia, Hyperammonemia, and Homocitrullinuria Syndrome
Mendel Tuchman, MD;
David S. Knopman, MD;
Vivian E. Shih, MD
Arch Neurol. 1990;47(10):1134-1137.
Abstract
 |  |
A 39-year-old man and his 42-year-old sister, both vegetarians, had episodic confusion for many years, but their mental function was normal between those episodes. They were recently diagnosed with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome. Hyperammonemia was documented during an episode of confusion in the male sibling but not in his sister. Both had elevated plasma ornithine, glutamine, and alanine levels and persistently low plasma lysine levels. Homocitrulline was present in their urine, and orotic aciduria and orotidinuria developed in the male sibling following ingestion of allopurinol. Studies on their cultured skin fibroblasts showed deficient metabolism of ornithine, indicating a defect in ornithine transport across the mitochondrial membrane. During therapy with citrulline and phenylbutyrate sodium, plasma ornithine levels increased in both patients, while plasma levels of glutamine and alanine decreased to normal. Since therapy started, their clinical conditions have also improved, and no recurrent neurologic dysfunction has occurred during a follow-up period of 20 months.
Author Affiliations
From the Departments of Pediatrics and Laboratory Medicine (Dr Tuchman) and Neurology (Dr Knopman), University of Minnesota, Minneapolis; and the Amino Acid Disorder Laboratory, Massachusetts General Hospital, Boston (Dr Shih).
Footnotes
Accepted for publication February 6, 1990.
Reprint requests to Department of Pediatrics, University of Minnesota, Box 400, Mayo Building, 420 Delaware St, Minneapolis, MN 55455 (Dr Tuchman).
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Hyperammonemia in the ICU
Clay and Hainline
Chest 2007;132:1368-1378.
ABSTRACT
| FULL TEXT
Optimization of Allopurinol Challenge: Sample Purification, Protein Intake Control, and the Use of Orotidine Response as a Discriminative Variable Improve Performance of the Test for Diagnosing Ornithine Carbamoyltransferase Deficiency
Arranz et al.
Clin. Chem. 1999;45:995-1001.
ABSTRACT
| FULL TEXT
|